PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsUrea c-13
Urea c-13
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
400 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223—C85.92762132290
Non-hodgkin lymphomaD008228—C85.9233331147
Mantle-cell lymphomaD020522—C83.1102341130
Hepatocellular carcinomaD006528—C22.031162425
CarcinomaD002277—C80.031261324
Liver neoplasmsD008113EFO_1001513C22.03962120
InfectionsD007239EFO_0000544—1—421320
Helicobacter infectionsD016481EFO_1000961——1—11012
Communicable diseasesD003141—————189
Diabetes mellitusD003920EFO_0000400E08-E13—114—6
Show 10 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938—C9513356—145
Large b-cell lymphoma diffuseD016403—C83.316245—136
Precursor cell lymphoblastic leukemia-lymphomaD054198—C91.06213—128
B-cell lymphomaD016393——13164—125
Follicular lymphomaD008224—C8210137—224
B-cell chronic lymphocytic leukemiaD015451—C91.19155—122
Hodgkin diseaseD006689—C819142—221
Myeloid leukemia acuteD015470—C92.08122—119
Burkitt lymphomaD002051—C83.76142—118
Lymphoid leukemiaD007945—C914161——18
Show 44 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
T-cell lymphomaD016399——35——28
Covid-19D000086382—U07.112——47
SyndromeD013577——35———6
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_0000340—15———6
Hematopoietic stem cell transplantationD018380——13——25
Waldenstrom macroglobulinemiaD008258—C88.033——15
Hematologic neoplasmsD019337——23———4
PreleukemiaD011289——24———4
Sickle cell anemiaD000755EFO_0000697D5711——34
Breast neoplasmsD001943EFO_0003869C5041———4
Show 96 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DyspepsiaD004415EFO_0008533K301———34
Stomach neoplasmsD013274EFO_0003897C161———34
T-cell lymphoma cutaneousD016410—C84.A2———13
Mycosis fungoidesD009182—C84.01———12
Pancreatic ductal carcinomaD021441——1———12
PorokeratosisD017499—L56.52————2
Pachyonychia congenitaD053549——2————2
TransplantationD014180——1————1
Hereditary breast and ovarian cancer syndromeD061325——1————1
Neurotoxicity syndromesD020258—G921————1
Show 9 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Acute kidney injuryD058186—N17————55
Kidney diseasesD007674EFO_0003086N08————55
Cardiovascular diseasesD002318EFO_0000319I98————44
Chronic kidney failureD007676EFO_0003884N18.6————33
SepsisD018805EFO_0001420A41.9————33
ToxemiaD014115——————33
Diabetic nephropathiesD003928EFO_0000401—————33
Heart failureD006333EFO_0003144I50————33
Inborn genetic diseasesD030342EFO_0000508—————22
Renal insufficiencyD051437—N19————22
Show 108 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 4,030 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
42 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use